Tilman Gerlach
Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?
Berg T, Sarrazin C, Hinrichsen H, Buggisch P, Gerlach T, Zachoval R, Zeuzem S. Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?. Hepatology (Baltimore, Md.) 2004; 39:1456-7; author reply 1457-8.
01.05.2004Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?
01.05.2004Hepatology (Baltimore, Md.) 2004; 39:1456-7; author reply 1457-8
Berg Thomas, Sarrazin Christoph, Hinrichsen Holger, Buggisch Peter, Gerlach Tilman, Zachoval Reinhart, Zeuzem Stefan
Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
Schirren C, Pape G, Nitschko H, Rau H, Schraut W, Baretton G, Diepolder H, Gruener N, Ulsenheimer A, Gerlach T, Zachoval R, Jung M. Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination. Journal of hepatology 2003; 39:397-404.
01.09.2003Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
01.09.2003Journal of hepatology 2003; 39:397-404
Schirren Carl Albrecht, Pape Gerd Rudolf, Nitschko Hans, Rau Horst-Guenter, Schraut Winfried, Baretton Gustavo, Diepolder Helmut Michael, Gruener Norbert Hubert, Ulsenheimer Axel, Gerlach Tilman, Zachoval Reinhart, Jung Maria-Christina
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
Gerlach T, Backmund M, Waechtler M, Schirren C, Schraut W, Ulsenheimer A, Jung M, Gruener N, Zachoval R, Diepolder H, Pape G. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125:80-8.
01.07.2003Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
01.07.2003Gastroenterology 2003; 125:80-8
Gerlach Tilman, Backmund M, Waechtler M, Schirren C Albrecht, Schraut Winfried W, Ulsenheimer Axel, Jung Maria-Christina, Gruener Norbert H, Zachoval Reinhart, Diepolder Helmut M, Pape Gerd R
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial
Berg T, Hopf U, Pape G, Wursthorn K, Nasser S, Goeser T, Spengler U, Herrmann E, Buggisch P, Gerlach T, Hinrichsen H, Kronenberger B, Zeuzem S. Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. Hepatology (Baltimore, Md.) 2003; 37:1359-67.
01.06.2003Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial
01.06.2003Hepatology (Baltimore, Md.) 2003; 37:1359-67
Berg Thomas, Hopf Uwe, Pape Gerd R, Wursthorn Karsten, Nasser Samer, Goeser Tobias, Spengler Ulrich, Herrmann Eva, Buggisch Peter, Gerlach Tilman, Hinrichsen Holger, Kronenberger Bernd, Zeuzem Stefan
Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
Ulsenheimer A, Gerlach T, Gruener N, Jung M, Schirren C, Schraut W, Zachoval R, Pape G, Diepolder H. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology (Baltimore, Md.) 2003; 37:1189-98.
01.05.2003Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
01.05.2003Hepatology (Baltimore, Md.) 2003; 37:1189-98
Ulsenheimer Axel, Gerlach Tilman, Gruener Norbert H, Jung Maria-Christina, Schirren Carl-Albrecht, Schraut Winfried, Zachoval Reinhart, Pape Gerd R, Diepolder Helmut M
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology (Baltimore, Md.) 2003; 37:600-9.
01.03.2003Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy
01.03.2003Hepatology (Baltimore, Md.) 2003; 37:600-9
Berg Thomas, Sarrazin Christoph, Herrmann Eva, Hinrichsen Holger, Gerlach Tilman, Zachoval Reinhart, Wiedenmann Bertram, Hopf Uwe, Zeuzem Stefan
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
Gruener N, Backmund M, Wächtler M, Hoffmann R, Schirren C, Diepolder H, Gerlach T, Ulsenheimer A, Jung M, Pape G. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. Journal of hepatology 2002; 37:866-9.
01.12.2002Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
01.12.2002Journal of hepatology 2002; 37:866-9
Gruener Norbert H, Backmund Markus, Wächtler Martin, Hoffmann Robert, Schirren Carl A, Diepolder Helmut M, Gerlach Tilman, Ulsenheimer Axel, Jung Maria-Christina, Pape Gerd R
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
Jung M, Zeuzem S, Trojan J, Whitehead E, Birtles E, Bailey J, Page M, Schirren C, Diepolder H, Gerlach T, Schraut W, Zachoval R, Grüner N, Pape G. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 2002; 20:3598-612.
04.10.2002Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
04.10.2002Vaccine 2002; 20:3598-612
Jung Maria-Christina, Zeuzem Stefan, Trojan Jörg, Whitehead Eve, Birtles Emma, Bailey John, Page Mark, Schirren Carl-Albrecht, Diepolder Helmut, Gerlach Tilman, Schraut Winfried, Zachoval Reinhart, Grüner Norbert, Pape Gerd R
Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clones
Diepolder H, Gruener N, Gerlach T, Jung M, Wierenga E, Pape G. Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clones. Journal of virology 2001; 75:7803-10.
01.09.2001Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clones
01.09.2001Journal of virology 2001; 75:7803-10
Diepolder H M, Gruener N H, Gerlach Tilman, Jung M C, Wierenga E A, Pape G R
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus
Gruener N, Pape G, Phillips R, Sullivan J, Walker B, Lauer G, Gerlach T, Diepolder H, Jung M, Lechner F, Klenerman P. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. Journal of virology 2001; 75:5550-8.
01.06.2001Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus
01.06.2001Journal of virology 2001; 75:5550-8
Gruener N H, Pape G R, Phillips R, Sullivan J, Walker B, Lauer G, Gerlach Tilman, Diepolder H, Jung M C, Lechner F, Klenerman P
Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease
Schirren C, Rau H, Houghton M, Zachoval R, Gruener N, Gerlach T, Baretton G, Mamin M, Worzfeld T, Jung M, Pape G. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease. The Journal of infectious diseases 2001; 183:1187-94.
15.04.2001Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease
15.04.2001The Journal of infectious diseases 2001; 183:1187-94
Schirren C A, Rau H G, Houghton M, Zachoval R, Gruener N H, Gerlach Tilman, Baretton G, Mamin M, Worzfeld T, Jung M C, Pape G R
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma
Schirren C, Jung M, Gerlach T, Worzfeld T, Baretton G, Mamin M, Hubert Gruener N, Houghton M, Pape G. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology (Baltimore, Md.) 2000; 32:597-603.
01.09.2000Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma
01.09.2000Hepatology (Baltimore, Md.) 2000; 32:597-603
Schirren C A, Jung M C, Gerlach Tilman, Worzfeld T, Baretton G, Mamin M, Hubert Gruener N, Houghton M, Pape G R
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection
Cucchiarini M, Pape G, Reichen J, Santantonio T, Grüner N, Gerlach T, Diepolder H, Grabscheid B, Kammer A, Cerny A. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cellular immunology 2000; 203:111-23.
01.08.2000Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection
01.08.2000Cellular immunology 2000; 203:111-23
Cucchiarini M, Pape G R, Reichen J, Santantonio T, Grüner N, Gerlach Tilman, Diepolder H M, Grabscheid B, Kammer A R, Cerny A
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C
Grüner N, Cerny A, Cucchiarini M, Santantonio T, Zachoval R, Hoffmann R, Schraut W, Schirren C, Diepolder H, Jung M, Gerlach T, Pape G. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. The Journal of infectious diseases 2000; 181:1528-36.
01.05.2000Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C
01.05.2000The Journal of infectious diseases 2000; 181:1528-36
Grüner N H, Cerny A, Cucchiarini M, Santantonio T, Zachoval R, Hoffmann R, Schraut W W, Schirren C A, Diepolder H M, Jung M C, Gerlach Tilman, Pape G R
Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection
Schirren C, Zachoval R, Diepolder H, Gerlach T, Gruener N, Baretton G, Mamin M, Worzfeld T, Jung M, Pape G. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000; 6:222-8.
01.03.2000Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection
01.03.2000Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000; 6:222-8
Schirren C A, Zachoval R, Diepolder H M, Gerlach Tilman, Gruener N H, Baretton G B, Mamin M, Worzfeld T, Jung M, Pape G R
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
Gerlach T, Santantonio T, Schirren C, Hoffmann R, Zachoval R, Schraut W, Gruener N, Jung M, Diepolder H, Pape G. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999; 117:933-41.
01.10.1999Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
01.10.1999Gastroenterology 1999; 117:933-41
Gerlach Tilman, Santantonio T, Schirren C A, Hoffmann R, Zachoval R, Schraut W W, Gruener N H, Jung M C, Diepolder H M, Pape G R
Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection
Jung M, Wächtler M, Santantonio T, Hoffmann R, Zachoval R, Grüner N, Schraut W, Gruber R, Diepolder H, Gerlach T, Hartmann B, Pape G. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 1999; 261:165-72.
01.09.1999Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection
01.09.1999Virology 1999; 261:165-72
Jung M C, Wächtler M, Santantonio T, Hoffmann R, Zachoval R, Grüner N, Schraut W, Gruber R, Diepolder H, Gerlach Tilman, Hartmann B, Pape G R
Role of the specific T-cell response for clearance and control of hepatitis C virus
Pape G, Gerlach T, Diepolder H, Grüner N, Jung M, Santantonio T. Role of the specific T-cell response for clearance and control of hepatitis C virus. Journal of viral hepatitis 1999; 6 Suppl 1:36-40.
01.07.1999Role of the specific T-cell response for clearance and control of hepatitis C virus
01.07.1999Journal of viral hepatitis 1999; 6 Suppl 1:36-40
Pape G R, Gerlach Tilman, Diepolder H M, Grüner N, Jung M, Santantonio T
Differential antigen-processing pathways of the hepatitis B virus e and core proteins
Diepolder H, Ries G, Jung M, Schlicht H, Gerlach T, Gr ner N, Caselmann W, Pape G. Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology 1999; 116:650-7.
01.03.1999Differential antigen-processing pathways of the hepatitis B virus e and core proteins
01.03.1999Gastroenterology 1999; 116:650-7
Diepolder H M, Ries G, Jung M C, Schlicht H J, Gerlach Tilman, Gr ner N, Caselmann W H, Pape G R
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B
Diepolder H, Scholz S, Schirren C, Hoffmann R, Zachoval R, Grüner N, Gerlach T, Schraut W, Keller E, Jung M, Pape G. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clinical and experimental immunology 1998; 113:244-51.
01.08.1998A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B
01.08.1998Clinical and experimental immunology 1998; 113:244-51
Diepolder H M, Scholz S, Schirren C A, Hoffmann R M, Zachoval R, Grüner N, Gerlach Tilman, Schraut W, Keller E, Jung M C, Pape G R